Cherwell Laboratories’ cleanroom microbiology solutions will join AnalytiChem’s group of seven companies across Europe, North America, and Australia.
The expansion will boost solid-phase peptide synthesis total reactor volume to 32,000 L.
The new Europe headquarters will be the hub for the company’s European operations, including production of product.
The midterm report of the European Medicines Agencies Network Strategy finds that the network has strengthened and is on track to achieve its objectives.
The final guidance document provides recommendations for designing a new registry or using an existing registry to support decisions regarding safety and effectiveness of a drug.
The agencies published a joint guidance document regarding quality development for breakthrough therapies and PRIME programs.
The Multi-annual AI Workplan creates a strategy to maximize the benefits and manage the risks of artificial intelligence.
The guidance document discusses the impact of clinical pharmacology considerations on peptide drug development.
The US District Court for the District of Massachusetts entered a consent decree of permanent injunction against Pharmasol Corporation for distributing adulterated drugs.
The new advisory committee will provide the agency with technical and scientific advice and recommendations on potential treatments for genetic metabolic diseases.